title: Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats.
abstract: Recent ex vivo findings have shown that morphine increases dopamine (DA) and xanthine oxidative metabolism and ascorbic acid (AA) oxidation in the rat striatum. In the present study, we evaluated the effects of subcutaneous daily morphine (20 mg/kg) administration on DA, dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), AA and uric acid in the striatum of freely moving rats using microdialysis. Dialysates were assayed by high performance liquid chromatography with electrochemical detection. On the first day, morphine administration caused a significant increase in extracellular DA, DOPAC, HVA, AA and uric acid concentrations over a 3 h period after morphine. In all treated rats (n = 7), individual concentrations of DOPAC + HVA were directly correlated with individual AA and uric acid concentrations. Last morphine administration on the 4th day increased DOPAC, HVA, AA and uric acid concentrations but failed to increase those of DA. Individual DOPAC + HVA concentrations were still directly correlated with individual AA and uric acid concentrations. These results suggest that systemic morphine increases both striatal DA release and DA and xanthine oxidative metabolism. Only the former effect undergoes tolerance. The increase in DA oxidative metabolism is highly correlated with that of xanthine. The subsequent enhancement in reactive oxygen species production may account for the increase in extracellular AA.
authors.affiliation: Institute of Pharmacology, University of Sassari, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Enrico
authors.forename: G
authors.initials: G
authors.lastname: Esposito
authors.forename: M A
authors.initials: MA
authors.lastname: Mura
authors.forename: L
authors.initials: L
authors.lastname: Fresu
authors.forename: G
authors.initials: G
authors.lastname: De Natale
authors.forename: E
authors.initials: E
authors.lastname: Miele
authors.forename: M S
authors.initials: MS
authors.lastname: Desole
authors.forename: M
authors.initials: M
authors.lastname: Miele
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D017551:Microdialysis; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014527:Uric Acid / Q000378:metabolism*
chemical_list: D009294:Narcotics; D015102:3,4-Dihydroxyphenylacetic Acid; D014527:Uric Acid; D009020:Morphine; D001205:Ascorbic Acid; D004298:Dopamine; D006719:Homovanillic Acid